US Patent Issued to GUANGZHOU BIO-GENE TECHNOLOGY on April 7 for "Anti-B7H3 antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,308, issued on April 7, was assigned to GUANGZHOU BIO-GENE TECHNOLOGY Co. LTD (Guangdong, China).

"Anti-B7H3 antibody and use thereof" was invented by Min Luo (Guangdong, China), Guangchao Li (Guangdong, China), Zhao Zhou (Guangdong, China) and Xuejun Wang (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an anti-B7H3 antibody and the use thereof. A variable region of the antibody comprises amino acid sequences as shown in SEQ ID NOs: 25-39. The anti-B7H3 antibodies 26B6, 6F7, 2B8, and 23H1 have a significant binding capability to B7H3, can not only bind to purified or free B7H3 protein, but also can bind to B7H3 protein ...